- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00098124
Study of Milnacipran for the Treatment of Fibromyalgia
December 18, 2007 updated by: Forest Laboratories
A Phase III Pivotal, Multicenter, Double-Blind, Randomized, Placebo-Controlled Study of Milnacipran for the Treatment of Fibromyalgia
Antidepressants of all varieties represent a common form of therapy for many chronic states including fibromyalgia.
The majority of antidepressants increase the levels of serotonin or norepinephrine in the central nervous system.
Milnacipran is a dual norepinephrine and serotonin reuptake inhibitor and may be effective in the treatment of fibromyalgia.
Study Overview
Study Type
Interventional
Enrollment
1200
Phase
- Phase 3
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Alabama
-
Birmingham, Alabama, United States, 35205
- Forest Investigative Site
-
Mobile, Alabama, United States, 36608
- Forest Investigative Site
-
Montgomery, Alabama, United States, 36111
- Forest Investigative Site
-
-
Arizona
-
Peoria, Arizona, United States, 85381
- Forest Investigative Site
-
-
California
-
Beverly Hills, California, United States, 90211
- Forest Investigative Site
-
Sacramento, California, United States, 95825
- Forest Investigative Site
-
San Diego, California, United States, 92117
- Forest Investigative Site
-
San Diego, California, United States, 92108
- Forest Investigative Site
-
Santa Ana, California, United States, 92705
- Forest Investigative Site
-
Spring Valley, California, United States, 91978
- Forest Investigative Site
-
Torrance, California, United States, 90505
- Forest Investigative Site
-
-
Colorado
-
Colorado Springs, Colorado, United States, 80909
- Forest Investigative Site
-
Colorado Springs, Colorado, United States, 80910
- Forest Investigative Site
-
-
Connecticut
-
Danbury, Connecticut, United States, 06810
- Forest Investigative Site
-
Stamford, Connecticut, United States, 06905
- Forest Investigative Site
-
Trumball, Connecticut, United States, 06611
- Forest Investigative Site
-
-
Florida
-
Clearwater, Florida, United States, 33761
- Forest Investigative Site
-
Deland, Florida, United States, 32720
- Forest Investigative Site
-
Delray Beach, Florida, United States, 33484
- Forest Investigative Site
-
Jacksonville, Florida, United States, 33216
- Forest Investigative Site
-
Ocala, Florida, United States, 34471
- Forest Investigative Site
-
Ormond Beach, Florida, United States, 32174
- Forest Investigative Site
-
Palm Harbor, Florida, United States, 34684
- Forest Investigative Site
-
Pembroke Pines, Florida, United States, 33029
- Forest Investigative Site
-
Port Orange, Florida, United States, 32127
- Forest Investigative Site
-
Tamarac, Florida, United States, 33321
- Forest Investigative Site
-
-
Georgia
-
Decatur, Georgia, United States, 30033
- Forest Investigative Site
-
-
Hawaii
-
Honolulu, Hawaii, United States, 96814
- Forest Investigative Site
-
-
Idaho
-
Meridian, Idaho, United States, 83642
- Forest Investigative Site
-
-
Illinois
-
Chicago, Illinois, United States, 60612
- Forest Investigative Site
-
Libertyville, Illinois, United States, 60048
- Forest Investigative Site
-
Peoria, Illinois, United States, 61614
- Forest Investigative Site
-
-
Indiana
-
Evansville, Indiana, United States, 47713
- Forest Investigative Site
-
Lafayette, Indiana, United States, 47904
- Forest Investigative Site
-
-
Kansas
-
Wichita, Kansas, United States, 67207
- Forest Investigative Site
-
-
Kentucky
-
Lexington, Kentucky, United States, 40509
- Forest Investigative Site
-
-
Maryland
-
Baltimore, Maryland, United States, 21237
- Forest Investigative Site
-
Columbia, Maryland, United States, 21045
- Forest Investigative Site
-
Frederick, Maryland, United States, 21702
- Forest Investigative Site
-
-
Massachusetts
-
Newton, Massachusetts, United States, 02462
- Forest Investigative Site
-
North Dartmouth, Massachusetts, United States, 02747
- Forest Investigative Site
-
-
Michigan
-
Kalamazoo, Michigan, United States, 49009
- Forest Investigative Site
-
-
Mississippi
-
Flowood, Mississippi, United States, 39232
- Forest Investigative Site
-
-
Missouri
-
St. Louis, Missouri, United States, 63141
- Forest Investigative Site
-
-
Montana
-
Missoula, Montana, United States, 59802
- Forest Investigative Site
-
-
New Jersey
-
Cherry Hill, New Jersey, United States, 08002
- Forest Investigative Site
-
Clementon, New Jersey, United States, 08021
- Forest Investigative Site
-
-
New Mexico
-
Santa Fe, New Mexico, United States, 87505
- Forest Investigative Site
-
-
New York
-
East Syracuse, New York, United States, 13057
- Forest Investigative Site
-
Great Neck, New York, United States, 11021
- Forest Investigative Site
-
Rochester, New York, United States, 14618
- Forest Investigative Site
-
-
North Carolina
-
Charlotte, North Carolina, United States, 28209
- Forest Investigative Site
-
Fayetteville, North Carolina, United States, 28304
- Forest Investigative Site
-
Hickory, North Carolina, United States, 28601
- Forest Investigative Site
-
Raleigh, North Carolina, United States, 27612
- Forest Investigative Site
-
Raleigh, North Carolina, United States, 27609
- Forest Investigative Site
-
Winston-Salem, North Carolina, United States, 27103
- Forest Investigative Site
-
-
North Dakota
-
Bismarck, North Dakota, United States, 58501
- Forest Investigative Site
-
-
Ohio
-
Marion, Ohio, United States, 43302
- Forest Investigative Site
-
-
Oklahoma
-
Oklahoma City, Oklahoma, United States, 73112
- Forest Investigative Site
-
-
Oregon
-
Bend, Oregon, United States, 97701
- Forest Investigative Site
-
Eugene, Oregon, United States, 97404
- Forest Investigative Site
-
Medford, Oregon, United States, 97504
- Forest Investigative Site
-
Portland, Oregon, United States, 97205
- Forest Investigative Site
-
-
Pennsylvania
-
Duncanville, Pennsylvania, United States, 16635
- Forest Investigative Site
-
-
Rhode Island
-
Warwick, Rhode Island, United States, 02886
- Forest Investigative Site
-
-
South Carolina
-
Orangeburg, South Carolina, United States, 29118
- Forest Investigative Site
-
-
Tennessee
-
Bristol, Tennessee, United States, 37620
- Forest Investigative Site
-
Chattanooga, Tennessee, United States, 37404
- Forest Investigative Site
-
Memphis, Tennessee, United States, 38119
- Forest Investigative Site
-
-
Texas
-
Austin, Texas, United States, 78705
- Forest Investigative Site
-
San Antonio, Texas, United States, 78205
- Forest Investigative Site
-
Sugarland, Texas, United States, 77479
- Forest Investigative Site
-
-
Virginia
-
Richmond, Virginia, United States, 23294
- Forest Investigative Site
-
Virginia Beach, Virginia, United States, 23454
- Forest Investigative Site
-
-
Washington
-
Bellingham, Washington, United States, 98226
- Forest Investigative Site
-
Everett, Washington, United States, 98201
- Forest Investigative Site
-
Seattle, Washington, United States, 98166
- Forest Investigative Site
-
Wenatchee, Washington, United States, 98801
- Forest Investigative Site
-
-
Wisconsin
-
Racine, Wisconsin, United States, 53406
- Forest Investigative Site
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 70 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Diagnosis of fibromyalgia defined by 1990 American College of Rheumatology (ACR) Criteria
Exclusion Criteria:
- Psychiatric illness
- Depression
- Suicidal risk
- Substance abuse
- Pulmonary dysfunction
- Renal impairment
- Active cardiac disease
- Liver disease
- Autoimmune disease
- Cancer
- Sleep apnea
- Inflammatory bowel disease
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
|---|
|
Composite responder analysis based on pain and patient global status, with or without physical function.
|
Secondary Outcome Measures
Outcome Measure |
|---|
|
Quality of Life
|
|
Health Assessment Questionnaire (HAQ) Disability Index
|
|
Fatigue, sleep and cognitive assessments
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
November 1, 2004
Study Completion
December 1, 2006
Study Registration Dates
First Submitted
December 3, 2004
First Submitted That Met QC Criteria
December 3, 2004
First Posted (Estimate)
December 6, 2004
Study Record Updates
Last Update Posted (Estimate)
December 24, 2007
Last Update Submitted That Met QC Criteria
December 18, 2007
Last Verified
December 1, 2007
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Nervous System Diseases
- Musculoskeletal Diseases
- Rheumatic Diseases
- Muscular Diseases
- Neuromuscular Diseases
- Fibromyalgia
- Myofascial Pain Syndromes
- Physiological Effects of Drugs
- Neurotransmitter Agents
- Molecular Mechanisms of Pharmacological Action
- Peripheral Nervous System Agents
- Analgesics
- Sensory System Agents
- Analgesics, Non-Narcotic
- Psychotropic Drugs
- Neurotransmitter Uptake Inhibitors
- Membrane Transport Modulators
- Antidepressive Agents
- Serotonin and Noradrenaline Reuptake Inhibitors
- Milnacipran
- Levomilnacipran
Other Study ID Numbers
- MLN-MD-02
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Fibromyalgia
-
Ionclinics & Deionic SLHospital Clínico Universitario de ValenciaNot yet recruitingFibromyalgia (FM)Spain
-
Ain Shams UniversityRecruiting
-
Selcuk UniversityNot yet recruiting
-
Fundació Institut de Recerca de l'Hospital de la...CompletedFibromyalgia (FM)Spain
-
Istanbul Gelisim UniversityBahçeşehir UniversityCompleted
-
Gazi UniversityCompletedFibromyalgia SyndromeTurkey (Türkiye)
-
University of UtahRecruitingFibromyalgia (FM)United States
-
María Catalina Osuna PérezActive, not recruitingFibromyalgia SyndromeSpain
-
Istanbul UniversityCompletedFibromyalgia | Fibromyalgia Syndrome | Fibromyalgia (FM)Turkey (Türkiye)
Clinical Trials on milnacipran hydrochloride
-
Indiana UniversityNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)Completed
-
Forest LaboratoriesCypress Bioscience, Inc.Completed
-
Pierre Fabre MedicamentCompletedFibromyalgia SyndromeSpain, Italy, Portugal, France, Czech Republic, Finland, Germany, Norway, Romania, Sweden, Denmark, Poland, United Kingdom
-
California Medical Clinic for HeadacheUnknownChronic Migraine | Migraine Without Aura | Migraine With AuraUnited States
-
Chang Gung Memorial HospitalUnknownDepression | Ischemic StrokeTaiwan
-
Dr. Norman HardenForest LaboratoriesCompletedChronic Pain | Knee Osteoarthritis | Degenerative Joint Disease
-
Pierre Fabre MedicamentCompletedFibromyalgia SyndromeSpain, Italy, Portugal, France, Czech Republic, Finland, Germany, Norway, Romania, Sweden
-
Valera BussellForest LaboratoriesCompleted
-
Forest LaboratoriesCypress Bioscience, Inc.Completed
-
Duke UniversityCompletedOsteoarthritis Pain | Knee Pain After Total Knee ArthroplastyUnited States